Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cyclosporine (sandimmune) (2023)
cyclosporine (sandimmune) (5 trials)
perfluorohexyloctane (Miebo) (3 trials)
nebivolol (bystolic) (1 trial)
timolol (blocadren) (1 trial)
Dry Eye Syndromes (Phase 3)
Eye Diseases (Phase 3)
Keratoconjunctivitis Sicca (Phase 3)
Signs and Symptoms (Phase 3)
Trials (9 total)
Trial APIs (4 total)